[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-340136-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-340136-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"zh","research-progress-of-circular-rna-circhipk3-in-non-small-cell-lung-cancer","环状RNA CircHIPK3在非小细胞肺癌中的研究进展","","肺癌是全球发病率与致死率均居前列的恶性肿瘤。尽管靶向治疗与免疫治疗持续推进，治愈仍是重大挑战。环状RNA（circRNA）因共价闭合结构稳定、序列保守以及疾病特异性表达而受到关注。既有研究提示circRNA失调参与多种癌症进展，其中circHIPK3作为由HIPK3基因第二外显子衍生的致癌性环状RNA，和非小细胞肺癌（NSCLC）的发生发展、分子机制、诊断、治疗及预后密切相关。本文综述其最新研究进展，旨在助力NSCLC精准诊疗。",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/research-progress-of-circular-rna-circhipk3-in-non-small-cell-lung-cancer/340136/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/research-progress-of-circular-rna-circhipk3-in-non-small-cell-lung-cancer/340136.png","ImageObject",300,407,{"name":42,"@type":43},"Rowan","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-24","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",6,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"circHIPK3的来源与主要定位是什么？","Question",{"text":63,"@type":64},"circHIPK3源于HIPK3基因的第二个外显子，与其二级结构相关的形成机制有关。既往研究指出其主要定位于细胞质，并在肺、乳腺、胰腺等组织细胞中高度表达。","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"circHIPK3可能通过哪些分子机制参与肿瘤发生发展？",{"text":68,"@type":64},"文中归纳circHIPK3可通过与蛋白相互作用、影响转录过程（与RNA聚合酶II复合物相互作用并下调特定基因表达）、调节表观遗传以及参与物质信息运输等机制发挥作用。",{"name":70,"@type":61,"acceptedAnswer":71},"circHIPK3在NSCLC早期诊断中如何体现价值？",{"text":72,"@type":64},"综述提到，基于细胞外囊泡（EVs）来源的circHIPK3在NSCLC中表达显著上调，并与TNM分期呈正相关。ROC分析显示其区分NSCLC患者与健康人群具有较高诊断效率（AUC=0.897）。","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},340136,1790272405,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":111,"language":139,"language_code":8,"site_id":7,"html_lang":140,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":117,"preview_page_count":33,"preview_urls":145},1099514067415,"https://ap-avatar.wpscdn.com/avatar/100002539d78ffe74a7?x-image-process=image/resize,m_fixed,w_180,h_180&k=1779092875211072502","中国肺癌杂志2 0 2 4年8月第2 7卷第8期 Chin J Lung Cancer, August 2 0 2 4 , Vol. 2 7 , No. 8  ·629 ·  \nDOI: 10.3779/j.issn.1009-3419.2024.106.20 ·综述 ·  \n环状RNA CircHIPK3在非小细胞肺癌中  \n的研究进展  \n王宇恒 陈亮  \n【摘要】 肺癌是全世界发病率和致死率最高的恶性肿瘤之一，虽然针对肺癌的靶向、免疫治疗等新兴治疗手段取得了显著进展，但如何治愈肺癌仍是一项备受瞩目的话题。其中环状RNA（ circular RNA, circRNA）作为最近发现的一类具有共价闭合结构的环状RNA，具有结构稳定、序列保守及疾病特异性表达等特点。当前医学前沿揭示了circRNA的失调与多种癌症的发展过程有关。其中，研究热点之一的环状RNA HIPK3（ circular RNA HIPK3, circHIPK3）是一种致癌基因，主要起源于基因HIPK3的第二个外显子。越来越多的证据表明circHIPK3参与了非小细胞肺癌（non-small cell lung cancer, NSCLC）等多种恶性肿瘤的发展，并且circHIPK3的异常表达与NSCLC的疾病机制、诊断、治疗以及预后密切相关。本文旨在对circHIPK3在NSCLC中的最新研究进展进行综述，以推动肺癌的精准诊疗。  \n【关键词】 环状RNA；HIPK3 ；肺肿瘤；竞争性内源性RNA ；生物标志物  \nResearch Progress of Circular RNA CircHIPK3 in Non-small Cell Lung Cancer  \nYuhengWANG, Liang CHEN  \nDepartment of Thoracic Surgery, First Affiliated Hospital of Nanjing Medical University, Nanjing 210000, China  \nCorresponding author: Liang CHEN, E-mail: [clbright0909@njmu.edu.cn](clbright0909@njmu.edu.cn)  \n【Abstract】 Lung cancer ranks among the most prevalent and deadliest malignancies worldwide. Despite significant strides in targeted therapies and immunotherapy for lung cancer, curing the disease remains a highly prioritized issue. Circular RNAs (circRNAs), recently discovered RNA molecules characterized by covalently closed loop structures, possess features such as structural stability, sequence conservation, and disease-specific expression. Cutting-edge medical research has linked circRNA dysregulation to the progression of various cancers. Among these, circular RNA HIPK3 (circHIPK3), an oncogenic gene primarily derived from the second exon of the HIPK3 gene, has emerged as a focal point of investigation. Increasing evidences suggest that circHIPK3 is involved in the development of non-small cell lung cancer (NSCLC) and other malignancies. Aberrant expression of circHIPK3 is closely associated with the disease mechanisms, diagnosis, treatment, and prognosis of NSCLC. This review discusses the latest research advancements on circHIPK3 in NSCLC, aiming to promote precise diagnosis and treatment of lung cancer.  \n【Keywords】 Circular RNA; HIPK3; Lung neoplasms; Competitive endogenous RNA; Biomarkers  \n【Copyright statement】 Copyright © 2024, Chinese Journal of Lung Cancer.  \n肺癌是一种主要起源于支气管黏膜上皮的恶性肿瘤[1]，在我国癌症发病率中占据很高的比例，也是目前肿瘤导致死亡的主要原因[2]。在肺癌的病理学分类中，可分为小细胞肺癌（small cell lung cancer, SCLC）和非小细胞肺癌（nonsmall cell lung cancer, NSCLC）两种主要的细胞学类型[2]。其中NSCLC更为常见，约占肺癌患者的85%[3]。目前，随着外科手术、化疗、放疗、免疫治疗等治疗方法的综合应用，  \n作者单位：210000南京，南京医科大学第一附属医院胸外科（通信作者：陈亮， E-mail: [clbright0909@njmu.edu.cn](clbright0909@njmu.edu.cn)）  \n早期肺癌的治愈率得到了显著的提升[4]，但晚期NSCLC患者的预后仍然较差，其5年生存率低于20%[5]。许多患者在确诊时已处于晚期，常常因为发生转移而错过手术时机[6]。因此，当务之急是进一步探索NSCLC发生及进展的分子机制，从而提高早期肺癌的生存率。  \n20世纪70年代，研究人员第一次在植物RNA病毒中检测出环状RNA（circular RNA, circRNA），起初它被认为是转录本错误剪接而产生的副产品[7]。然而，随着转录组测序技术的进展，科学家们发现circ RNA是由RNA 聚合酶II转录形成的内源性RNA，可分为非编码和编码  \n·630 · 中国肺癌杂志2 0 2 4年8月第2 7卷第8期 Chin J Lung Cancer, August 2 0 2 4 , Vol. 2 7 , No. 8  \ncircRNA，相较于线性RNA，circRNA的闭合环状结构使其对核酸外切酶具有更强的抵抗性[8]。由于circRNA有着结构稳定、疾病特异性表达和抗降解性等特点，很快掀起了对非编码RNA的研究浪潮[9]。其中circRNA HIPK3（circ RNA HIPK3, circHIPK3）作为一种新发现的circRNA，与 NSCLC的诊断、治疗和预后评估密切相关[10]。本篇综述通过总结国内外文献，就circHIPK3在NSCLC中的作用机制及研究进展进行总结，为NSCLC的早期诊断和治疗提供新的方法。  \n1 CircHIPK3概述  \nCirc HIPK 3起源于同源结构域相互作用蛋白激酶3 （homeodomain-interacting protein kinase 3, HIPK 3）基因的第二个外显子（图1），与大多数circRNA一样，circHIPK3主要定位于细胞质中，且其在肺、乳腺、胰腺等其他器官的组织细胞质中高度表达[11]。既往研究[11]证实了circHIPK3 可以通过以下分子机制参与肿瘤的发生发展：（1）与蛋白质相互作用：circHIPK3可以与某些蛋白质如RNA结合蛋白（RNA-binding protein, R BP）相互作用，干扰或增强其功能；（2）基因转录调节：在转录过程中发挥作用，与聚合酶 II复合物相互作用，下调特定基因的表达；（3）调节表观遗传；（4）运输物质信息。除此而外，circHIPK3参与了多种癌症的发生和发展的过程，在肺癌[12-16]、膀胱癌[17]、胃癌[18,19]、肾癌[20]、前列腺癌[21,22]、口腔鳞状细胞癌[23]、卵巢癌[24]、宫颈癌[25]、结直肠癌[2 6]、肝细胞癌[27]、胰腺癌[2 8]、心脏纤维化[29]、甲状腺癌[30]等疾病的发生发展中起到了重要的作用  \n（表1[12-24,26]）。  \n2 CircHIPK3与NSCLC的关系  \n2 .1 Circ HIPK 3作为NSCLC的新型诊断生物标志物 由于NS CLC的早期诊断检查费用昂贵，且临床影像学诊断的准确性有限，至今不能取得满意的效果，因此寻找适合的NS CLC的诊断生物标志物具有重要意义[31]。既往研究[3 2 , 3 3]表明circ RNA可作为早期诊断的新兴标志物。细胞外囊泡（extracellular vesicles, E Vs）是指含有各种核酸如微小RNA（microRNA, miRNA","cbCaifc29rNAuuqD","https://ap.wps.com/l/cbCaifc29rNAuuqD","pdf",1325119,"Chinese","en","# 摘要\n## 引言与研究背景\n## 1 CircHIPK3概述\n## 2 CircHIPK3与NSCLC的关系\n### 2.1 诊断生物标志物","[{\"question\":\"circHIPK3的来源与主要定位是什么？\",\"answer\":\"circHIPK3源于HIPK3基因的第二个外显子，与其二级结构相关的形成机制有关。既往研究指出其主要定位于细胞质，并在肺、乳腺、胰腺等组织细胞中高度表达。\"},{\"question\":\"circHIPK3可能通过哪些分子机制参与肿瘤发生发展？\",\"answer\":\"文中归纳circHIPK3可通过与蛋白相互作用、影响转录过程（与RNA聚合酶II复合物相互作用并下调特定基因表达）、调节表观遗传以及参与物质信息运输等机制发挥作用。\"},{\"question\":\"circHIPK3在NSCLC早期诊断中如何体现价值？\",\"answer\":\"综述提到，基于细胞外囊泡（EVs）来源的circHIPK3在NSCLC中表达显著上调，并与TNM分期呈正相关。ROC分析显示其区分NSCLC患者与健康人群具有较高诊断效率（AUC=0.897）。\"}]","环状RNA CircHIPK3在非小细胞肺癌中的研究进展 | PDF",1790034435,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c1b9a408e7931c92a7e21f84dd85a0e6.webp",983,1369,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/39d3c55caadfceee030d2880c84b2f46.webp",982,1368,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4a4a7c63ea10c8268b90228531a75686.webp",981,1367,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/31cb660438ad5b3d5fa793647f3b2bc7.webp",980,1365]